Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial)

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2018

Study Completion Date

July 31, 2018

Conditions
Atrial Fibrillation
Interventions
DEVICE

ICD with DX system

Implantable cardioverter defibrillator (ICD) system implantation with single lead with ventricular sensing and pacing and defibrillation combined with dedicated atrial sensing dipole.

Trial Locations (8)

10021

Weill Cornell Medical College, New York

10532

Westchester Medical Center, Valhalla

19141

Einstein Medical Center, Philadelphia

35294

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University, Nashville

43210

The Ohio State Wexner University Medical Center, Columbus

43615

Promedica Heart and Vascular Institute, Toledo

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Biotronik, Inc.

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER

NCT02186704 - Sensing Atrial High Rate Episodes With Implantable Cardioverter-Defibrillators Trial (The SENSE Trial) | Biotech Hunter | Biotech Hunter